This article for the Atlantic outlines Biden’s lukewarm stance on legalization and more. Current legalization measures harness bipartisan support, for reasons ranging from increased tax revenue for cities, to criminal justice reform. Biden, however, "Won’t inhale." He’s looking for more concrete research, he says.
In new research by the University of Nebraska and the Texas Biomedical Research Institute, cannabis (specifically, its anti-inflammatory cannabinoids) has been promising as a potential treatment aid for patients with COVID-19. Read the full article on Forbes.com.
Sales figures for U.S. cannabis have increased by 40% in 2020. This article for MJbizdaily.com details the retail growth, and optimistic predictions for the market in years to come.
Two Canadian scientists have emerged with research that certain cannabinoids may have preventative value for COVID-19. Read this Forbes article by Emily Price, and their attached research here: https://www.forbes.com/sites/emilyprice/2020/06/27/researchers-are-looking-at-cannabis-as-a-potential-way-to-prevent-covid-19/#74785497d885
Although policies are taking steps in the right direction, business owners and cannabis operators continue to express concern over dysfunctional licensing processes. https://abcnews.go.com/US/wireStory/los-angeles-boost-ailing-legal-marijuana-market-71418124
You may have been hearing more about TCPA these days. Lawsuits are stacking up in the industry, read this article to find out how you can stay ahead. https://www.cannabisdispensarymag.com/article/why-cannabis-businesses-should-think-before-they-text-tcpa/
This story was first reported on Marijuana Moment. https://www.marijuanamoment.net/bernie-sanders-calls-for-marijuana-legalization-in-senate-floor-speech-on-policing-reform/
Last year, Oregon banned all flavored vaping products, a ban which the courts quickly overturned. Now, the Oregon Liquor Control Commission is presenting the possibility for new regulation: this time limited to THC vaping products. There has been significant pushback, some of which is outlined in this article by Oregon Public Broadcasting. Further steps are unclear, but we do expect
A lack of consistent industry regulations surrounding vaporizers has left cannabis businesses more vulnerable than ever. As of January 2020, the Centers for Disease Control and Prevention confirmed over 2,600 cases of vaping-related illnesses in all 50 states—including 59 fatalities. The outbreak has pushed the issue of product liability to the forefront of the cannabis industry. “In 2019, we saw a
Take action for black lives here. (And don’t forget, silence = violence.) Learn more about the ongoing war on drugs with this article by the Marijuana Policy Project.